NCT00556192 Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT00541749 A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT00539838 A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) Status TERMINATED Phase PHASE3
NCT00527176 Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity Status UNKNOWN Phase N/A
NCT00522002 CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study Status COMPLETED Phase N/A
NCT00519363 Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors Status COMPLETED Phase PHASE1/PHASE2
NCT00508898 The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria Status WITHDRAWN Phase PHASE4
NCT00504244 Myfortic Versus Azathioprine in Systemic Lupus Erythematosus Status TERMINATED Phase PHASE3
NCT00479622 Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus Status TERMINATED Phase PHASE1
NCT00432354 An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE2/PHASE3
NCT00430677 Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Status TERMINATED Phase PHASE2/PHASE3
NCT00424476 A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE3